Credit Suisse’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$12.4M Sell
118,317
-1,097
-0.9% -$98.6K 0.01% 822
2023
Q4
$9.02M Buy
119,414
+229
+0.2% +$14.5K 0.01% 976
2023
Q3
$7.85M Sell
119,185
-7,674
-6% -$574K 0.01% 1020
2023
Q2
$10.3M Buy
126,859
+12,318
+11% +$877K 0.01% 911
2023
Q1
$6.81M Sell
114,541
-9,157
-7% -$509K 0.01% 1121
2022
Q4
$6.04M Buy
123,698
+1,742
+1% +$80.5K 0.01% 1192
2022
Q3
$6.29M Buy
121,956
+6,703
+6% +$398K 0.01% 1131
2022
Q2
$6.06M Buy
115,253
+11,847
+11% +$824K 0.01% 1169
2022
Q1
$8.89M Sell
103,406
-14,187
-12% -$1.17M 0.01% 1102
2021
Q4
$9.61M Buy
117,593
+27,481
+30% +$2.01M 0.01% 1534
2021
Q3
$5.99M Sell
90,112
-15,346
-15% -$1.09M ﹤0.01% 1915
2021
Q2
$6.96M Sell
105,458
-9,492
-8% -$589K ﹤0.01% 1813
2021
Q1
$5.98M Buy
114,950
+1,059
+0.9% +$53.5K ﹤0.01% 1932
2020
Q4
$4.55M Sell
113,891
-29,974
-21% -$967K ﹤0.01% 2173
2020
Q3
$3.53M Buy
143,865
+15,698
+12% +$401K ﹤0.01% 2020
2020
Q2
$2.32M Sell
128,167
-16,672
-12% -$328K ﹤0.01% 2260
2020
Q1
$2.09M Buy
144,839
+29,663
+26% +$851K ﹤0.01% 2113
2019
Q4
$4.38M Sell
115,176
-173,890
-60% -$5.21M ﹤0.01% 1977
2019
Q3
$6.39M Buy
289,066
+202,440
+234% +$4.31M 0.01% 1578
2019
Q2
$1.79M Sell
86,626
-48,587
-36% -$1.12M ﹤0.01% 2537
2019
Q1
$3.9M Sell
135,213
-9,424
-7% -$233K ﹤0.01% 1908
2018
Q4
$2.48M Sell
144,637
-50,189
-26% -$1.21M ﹤0.01% 2077
2018
Q3
$5.54M Sell
194,826
-16,271
-8% -$537K 0.01% 1630
2018
Q2
$7.09M Buy
211,097
+75,232
+55% +$2.34M 0.01% 1474
2018
Q1
$3.29M Sell
135,865
-508,655
-79% -$10.1M ﹤0.01% 2019
2017
Q4
$9.77M Buy
644,520
+31,648
+5% +$445K 0.01% 1305
2017
Q3
$10.1M Buy
612,872
+295,876
+93% +$5.02M 0.01% 1250
2017
Q2
$6.13M Buy
316,996
+63,675
+25% +$1.11M 0.01% 1502
2017
Q1
$4.49M Sell
253,321
-71,376
-22% -$1.32M ﹤0.01% 1732
2016
Q4
$4.82M Buy
324,697
+120,916
+59% +$2.17M ﹤0.01% 1676
2016
Q3
$4.62M Buy
203,781
+59,000
+41% +$1.54M ﹤0.01% 1724
2016
Q2
$4M Buy
144,781
+16,656
+13% +$492K ﹤0.01% 1795
2016
Q1
$3.71M Buy
128,125
+26,247
+26% +$683K ﹤0.01% 1750
2015
Q4
$3.09M Sell
101,878
-57,392
-36% -$1.88M ﹤0.01% 1955
2015
Q3
$5.88M Sell
159,270
-108,873
-41% -$5.63M 0.01% 1451
2015
Q2
$15.5M Buy
268,143
+16,604
+7% +$848K 0.02% 972
2015
Q1
$12.5M Sell
251,539
-23,446
-9% -$1.1M 0.01% 1072
2014
Q4
$13.9M Buy
274,985
+170,686
+164% +$8.92M 0.01% 1064
2014
Q3
$6.2M Sell
104,299
-61,099
-37% -$3.41M 0.01% 1597
2014
Q2
$7.76M Sell
165,398
-9,140
-5% -$413K 0.01% 1589
2014
Q1
$7.47M Buy
174,538
+10,767
+7% +$475K 0.01% 1448
2013
Q4
$6.9M Buy
163,771
+53,741
+49% +$2.34M 0.01% 1566
2013
Q3
$4.53M Sell
110,030
-191,035
-63% -$7.99M ﹤0.01% 1724
2013
Q2
$13.9M Buy
+301,065
New +$13.5M 0.01% 951

Other funds holding THC

Credit Suisse's THC Position: Q1 2024 in Review

Credit Suisse reduced its Tenet Healthcare (THC) stake by 0.92% in Q1 2024, selling an estimated $98.6K and leaving 118,317 shares worth $12.4M. The position accounts for 0.01% of the portfolio, ranked #822.

Credit Suisse first reported a position in THC in Q2 2013 and has held it in 44 quarters since. The position peaked at $15.5M in Q2 2015. 460 funds tracked by Wall St. Rank hold THC as of Q1 2024.

  • Credit Suisse held 118,317 shares of Tenet Healthcare worth $12.4M as of Q1 2024.
  • Credit Suisse sold 1,097 Tenet Healthcare shares in Q1 2024, an estimated $98.6K.
  • Tenet Healthcare made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #822 holding.
  • Credit Suisse first reported a position in Tenet Healthcare in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Tenet Healthcare position peaked at $15.5M in Q2 2015.
  • 460 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.